1. Home
  2. NVR vs NBIX Comparison

NVR vs NBIX Comparison

Compare NVR & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NVR Inc.

NVR

NVR Inc.

HOLD

Current Price

$6,368.31

Market Cap

15.9B

ML Signal

HOLD

Logo Neurocrine Biosciences Inc.

NBIX

Neurocrine Biosciences Inc.

HOLD

Current Price

$166.05

Market Cap

15.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NVR
NBIX
Founded
1980
1992
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.9B
15.5B
IPO Year
1995
1996

Fundamental Metrics

Financial Performance
Metric
NVR
NBIX
Price
$6,368.31
$166.05
Analyst Decision
Hold
Strong Buy
Analyst Count
7
29
Target Price
★ $6,229.67
$207.50
AVG Volume (30 Days)
35.7K
★ 1.3M
Earning Date
10-22-2026
11-02-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 41.95
EPS
★ 151.38
5.26
Revenue
★ $10,323,959,000.00
$161,626,000.00
Revenue This Year
N/A
$36.46
Revenue Next Year
N/A
$17.43
P/E Ratio
$39.99
★ $31.49
Revenue Growth
N/A
★ 977.51
52 Week Low
$5,501.01
$122.14
52 Week High
$8,200.00
$186.12

Technical Indicators

Market Signals
Indicator
NVR
NBIX
Relative Strength Index (RSI) 51.04 76.47
Support Level $5,555.93 $152.67
Resistance Level $6,398.08 $169.57
Average True Range (ATR) 230.41 3.61
MACD 38.12 2.23
Stochastic Oscillator 64.76 86.44

Price Performance

Historical Comparison
NVR
NBIX

About NVR NVR Inc.

NVR Inc is engaged in the construction and sale of residential properties, including single-family detached homes, townhomes, and condominium buildings, all of which are built on a pre-sold basis. Additionally, the company provides related services through its mortgage banking and title services businesses. Its business segments are Homebuilding and Mortgage Banking. Its geographical segments include the Mid Atlantic, the North East, the Mid East, and the South East regions of America. The majority of the company's revenue is derived from the Homebuilding Mid Atlantic segment, which includes homebuilding operations that construct and sell single-family detached homes, townhomes and condominiums in Maryland, Virginia, West Virginia, Delaware and Washington, D.C. regions.

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.

Share on Social Networks: